Wednesday, April 28, 2010 |
12:30:00 |
Registration |
|
13:25:00 |
Inhibiting HCV Polymerase (NS5B) |
|
13:30:00 |
Chairperson's Opening Remarks |
|
13:40:00 |
Structure-Based Design of Non-Nucleoside NS5B Inhibitors for the Treatment of HCV |
Francisco Talamas
|
14:10:00 |
PSI-7851: Development of a Nucleotide Prodrug for the Treatment of HCV |
Michael J. Sofia
|
14:40:00 |
Novel Phosphoramidate HCV NS5b Inhibitors |
Joseph M Patti
|
15:10:00 |
Sponsored Presentations (Opportunity Available) |
|
15:40:00 |
Networking Refreshment Break, Poster and Exhibit Viewing |
|
16:15:00 |
Inhibiting HCV NS5A |
|
16:20:00 |
The Identification and Optimization of HCV Replicon Inhibitors Characterised by NS5A Specific Mutations |
Stuart Cockerill
|
16:50:00 |
Discovery and Characterization of PPI-461, a Potent and Selective HCV NS5A Inhibitor with Broad-Spectrum Coverage of all HCV Genotypes |
Richard Colonno
|
17:20:00 |
Break-Out Discussions |
|
18:30:00 |
End of Day |
|
Thursday, April 29, 2010 |
07:30:00 |
Breakfast Workshop Presentation (Sponsorship Opportunity Available) or Morning Coffee |
|
08:10:00 |
Inhibiting HCV Protease |
|
08:15:00 |
Chairperson's Opening Remarks |
|
08:20:00 |
KEYNOTE Telaprevir: Discovery, Homologues and Clinical Update |
Youssef Bennani
|
09:00:00 |
Protein Silencing of Hepatitis C Virus NS3/4A Protease in vitro and in vivo With AVL-181 |
Juswinder Singh
|
09:30:00 |
Recent Developments in HCV NS3/4A Protease Inhibitor |
Nigel Liverton
|
10:00:00 |
Networking Coffee Break, Poster and Exhibit Viewing |
|
10:45:00 |
Boron and Non-Boron-Based HCV NS3/4 Protease InIhibitors: Discovery of a Novel Motif Possessing High Potency against PI-Resistant Mutants |
Wieslaw Kazmierski
|
11:15:00 |
HCV-Protease Inhibitors: Current and the Next Generation |
Atul Agarwal
|
11:45:00 |
TMC435 Clinical Update and In Vitro Combination |
Kenny Simmen
|
12:15:00 |
Sponsored Presentation (Opportunity Available) |
|
12:30:00 |
Walk and Talk Luncheon in the Exhibit Hall (Last Chance for Poster and Exhibit Viewing) |
|
13:50:00 |
New Viral Targets |
|
13:55:00 |
Chairperson's Remarks |
|
14:00:00 |
Discovery of Potent and Mechanistically Distinct Inhibitors of HCV Entry |
William C. Olson
|
14:30:00 |
Core Protein: A New Target for the Development of Novel Small Molecule Inhibitors of HCV |
A. Donny Strosberg
|
15:00:00 |
Networking Refreshment Break |
|
15:15:00 |
Targeting The Host |
|
15:20:00 |
Development of SR-B1 Modulators as HCV Entry Inhibitors |
Jeffrey McKelvy
|
15:50:00 |
Targeting TLR7 |
James Appleman
|
16:20:00 |
Mechanism of HCV Resistance to Cyclophilin Inhibitors |
Hengli Tang
|
16:50:00 |
End of Conference |
|